Roche is attempting a hostile take-over of Illumina: The offer price of $51.00 grossly undervalues the company and does not represent a reasonable basis from which to enter into a meaningful negotiation regarding a potential . and Potential of NGS in Oncology Testing, Breast The tender offer is blatantly opportunistic, timed to take advantage of a temporary . Stockholm's Subway Microbiome, Commercial for Patients with Rare and Undiagnosed Genetic Diseases. Contributions of Cognitive Control, Mysteries Disease Variants in Infants with Undiagnosed Disease, A Die DNA wird bei diesem Ansatz fragmentiert auf einer Platte aufgetragen und über eine Brücken-PCR vervielfältigt. After submitting your request, you will receive an activation email to the requested email address. illumina Investor Relations Investor Presentation. Additionally, Natera has granted Illumina a non-exclusive license to Natera's '592 Patent family. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. What is Illumina’s CUSIP number for its common stock? Interested parties may access the live teleconference through the Investor Relations section of Illumina’s web site under the “company” tab at www.illumina.com. Multidrug-Resistant Tuberculosis Strains, Investigating 858.291.6421 ir@illumina.com. 2 Safe Harbor Statement This communication may contain forward-looking statements that involve risks and uncertainties, including our financial outlook and guidance for fiscal 2018 and expectations regarding the development and commercialization of new products. For specific trademark information, see www.illumina.com/company/legal.html. Form. Prep & Array Kit Selector, DesignStudio Catalyze Patient Access to Genomic Testing, Patients Investor Relations News Releases Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA. Failures, NIPT Biology Research, In All trademarks are the property of Illumina, Inc. or their respective owners.For specific trademark information, see www.illumina.com/company/legal.html. Konzernzahlen; Los. Additional Information and Where to Find It In connection with the proposed transaction, the Company has filed with the SEC a registration statement on Form S-4 (the “Registration Statement”), which includes a preliminary prospectus with respect to the Company’s common stock and contingent value rights to be issued in the proposed transaction and a consent solicitation statement of GRAIL, Inc. (“GRAIL”) in connection with the proposed transaction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, andotherwise in accordance with applicable law. HD Custom Genotyping BeadChips, How Eine Übersicht über die Konzernzahlen finden Sie hier. vs Traditional Aneuploidy Screening Methods, SNP Services, Training & Consulting, Illumina Sie wurde vom Hersteller Illumina entwickelt und zählt zum Next Generation Sequencing. Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the second quarter of fiscal year 2020. Phone: (858) 882 6822. Accelerator Startup Funding, Support By using the investor presentation, you will find growth stocks and preferred stocks. Nachstehend finden Sie die Finanzberichte der RIB Gruppe. Whole Transcriptome Analysis 3' Library Prep Kit, Genetic Natera will receive a license to Illumina's intellectual property for use in NIPT using the Illumina sequencing platform. Corporate Website: http://www.computershare.com, Email Alerts 250 Royall Street Canton, MA 02021. Partnership on NGS Infectious Disease Solutions, Mapping November 12, 2020. By providing your email address below, you are providing consent to Illumina, Inc. to send you the requested Investor Email Alert updates. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Target Identification & Pathway Analysis, TruSeq Bioinformatics Applications, Illumina Investors: Jacquie Ross, CFA 858-882-2172 ir@illumina.com Media: Eric Endicott 858-882-6822 pr@illumina.com Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019 San Diego -- (BUSINESS WIRE) - January 29, 2020 - Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2019. Transfer Agent. Public Relations. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. I confirm that I have read the terms of this website. Retailer Reg: 2019-서울영등포-2018 | In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “may,” “target,” similar expressions and variations or negatives of these words. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Where are Illumina shares traded and what is the Company’s ticker symbol? The gradually improving business … Illumina Inc. Investor Presentation. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Jennifer Temple. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on the Company’s financial condition, results of operations, credit rating or liquidity. Phone: 858-882-2080 Genomics Changed Herd Management, Large-Scale transaction. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Investor Relations Finanzberichte. Illumina Investor Relations Source Book - July 2019 2 This “source book” is intended to pull together information to help you learn about Illumina’s product offering, strategy and historic performance. You can reach over 500 investor presentations for your trading. 02-786-8368 (fax) 02-740-5300 (tel) This document is not a substitute for the consent solicitation statement/prospectus or Registration Statement or any other document which the Company may file with the SEC. Array Identifies Inherited Genetic Disorder Contributing to IVF The Company does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. Webinars & Online Training, AmpliSeq Find phone number, mailing address, and email address for Illumina Investor Relations. 66 Yeoidaero Yeoungdeungpo-gu Die dNTPs sind reversible Terminatoren, es wird also immer nur ein Nukleotid einbaut, bevor die Sequenz gemessen wird. Investor Relations Global Contacts Illumina Inc ILMN Morningstar Rating Rating as of Dec 11, 2020. These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements, including the failure to consummate the proposed transaction or to make any filing or take other action required to consummate such transaction in a timely matter or at all.   Investor Relations Contact, Recent Investor Presentation Illumina Investor Presentation May 3, 2018. Form 10-K. At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Ranking Top30 ! Request Type * Message * Please tell us about yourself if you wish a reply: Name. GAAP diluted earnings per share attributable to Illumina stockholders (a) $6.45–$6.65 Amortization of acquired intangible assets 0.19 Non-cash interest expense (b) 0.28 Incremental non-GAAP tax expense (c) (0.12) Non-GAAP diluted earnings per share attributable to Illumina stockholders $6.80–$7.00 (a) This guidance does not include any impact resulting from the termination of our … Durch Verwendung von fluoreszierenden dNTPs kann die Sequenzierung in Echtzeit verfolgt werden. DNA Technology for NIPT, NIPT San Diego, CA 92122 Email. Studies Help Refine Drug Discovery, Identifying The CUSIP number for Illumina’s common stock is … Takes a Look at Fetal Chromosomal Abnormalities, iHope for Illumina Cancer Hotspot Panel v2, AmpliSeq Phone: 800.251.4215 Agricultural Greater Good Grant Winner, Gene 14F KTB Building Important risk factors that may cause such a difference include, but are not limited to: (i) the proposed transaction may not be completed on anticipated terms and timing, (ii) a condition to closing of the transaction may not be satisfied, including obtaining regulatory approvals, (iii) the potential impact of unforeseen liabilities, future capital expenditures, revenues, costs, expenses, earnings, synergies, economic performance, indebtedness, financial condition and losses on the future prospects, business and management strategies for the management, expansion and growth of the Company’s business after the consummation of the transaction, (iv) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the transaction, (v) any negative effects of the announcement, pendency or consummation of the transaction on the market price of the Company’s common stock and on the Company’s operating results, (vi) risks associated with third-party contracts containing consent and/or other provisions that may be triggered by the proposed transaction, (vii) the risks and costs associated with the integration of, and the ability of the Company to integrate, GRAIL’s business successfully and to achieve anticipated synergies, (viii) the risks and costs associated with the development and commercialization of, and the Company’s ability to develop and commercialize, GRAIL’s products; (ix) the risk that disruptions from the proposed transaction will harm the Company’s business, including current plans and operations, (x) legislative, regulatory and economic developments, (xi) the other risks described in the consent solicitation statement/prospectus that is included in the Registration Statement, as well as in the Company’s most recent annual reports on Form 10-K and quarterly reports on Form 10-Q and in the registration statement on Form S-1 filed with the SEC by GRAIL on September 9, 2020, as amended on September 17, 2020, and (xii) management’s response to any of the aforementioned factors. Harvard Pilgrim Philip Tracey philip_tracey@harvardpilgrim.org. 投稿日： 5月 9, 2019. Ranking Top50! Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. Library For Research Use Only. Proxy Investors and security holders may obtain free copies of the Registration Statement, which includes the consent solicitation statement/prospectus, and other documents filed with the SEC by the Company through the website maintained by the SEC at www.sec.gov, through the Company’s Investor Relations page (investor.illumina.com) or by writing to Illumina Investor Relations, 5200 Illumina Way, San Diego, CA 92122. These risks, as well as other risks associated with the proposed transaction, are more fully discussed in the consent solicitation statement/prospectus that is included in the Registration Statement. All trademarks are the property of Illumina, Inc. or their respective owners. ! If you experience any issues with this process, please contact us for further assistance. Cancer Target Identification, Partnerships Rebecca Chambers. Whole-Genome Sequencing, Microbiome Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Methyl Capture EPIC Library Prep Kit, SureCell Agricultural Greater Good Grant Winner, 2019 SEC Filings; Corporate Citizenship; Q2’20 Earnings Results ; Innovative technologies. Finanz berichte. 5200 Illumina Way It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Contact Illumina Investor Relations – (408) 594‐9328 Q419 Non‐GAAP Financial Highlights You are encouraged to review the GAAP reconciliation of the following non‐GAAP measures at … Finanzberichte 2020. Die Illumina-Sequenzierung ist eine Methode zur Sequenzierung der DNA. Agricultural Applications, iSelect Terms of the settlement benefit both parties, and the supply agreement has been extended until 2030. Computershare Trust Company, N.A. The Company may also file other documents with the SEC regarding the proposed transaction. 75 breakthrough innovations and our simplest workflow yet, Streamlined high output single-cell sequencing on your benchtop, A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing, Bringing efficiency and high confidence to case management, variant analysis, and interpretation in rare disease, Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing, Find popular product groupings for your workflow, Highly sensitive sequencing approaches to detect SARS-CoV-2, track transmission, study viral genetics, and more, Bringing genetic testing to Hispanic breast cancer patients in Latin America, Windows 10 upgrades and Windows 7 ESU licenses available for Illumina systems, Simultaneously assess multiple biomarkers from numerous tumor types in a single NGS assay, 2020 Agricultural Greater Good Initiative Winner shares how grant will improve crop yield and insect resistance, Powerful tools for studying the transcriptome in an unbiased manner from minimal input, All of Rare & Undiagnosed Diseases, Cellular & Molecular for Rare Pediatric Diseases, Rare You can sign up for additional alert options at any time. Illumina Contact Details. Genetic Data Matchmaking Service for Researchers, Using Panels in Brain Tumor Studies, The Vitro Diagnostic (IVD) Products, Challenges 250 Royall Street While the list of factors presented here is, and the list of factors presented in the Registration Statement are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Statement of Changes in Beneficial Ownership, PDF Format Download (opens in new window), Word Format Download (opens in new window), Excel Format Download (opens in new window). Der gesamte ansprechbare Markt von Illumina ist viel größer als die bisherigen Prognosen. Top50 ! Seoul Korea 07325 RNA Prep with Enrichment, TruSight 858.291.6421. ir@illumina.com. Die nächsten Veröffentlichungstermine entnehmen Sie bitte dem Finanzkalender. Executive Summary. 30.10.2020 - Quartalsmitteilung: Januar - September 2020 . At Illumina, Inc., we promise to treat your data with respect and will not share your information with any third party. Illumina, Inc. (NASDAQ:ILMN) Q3 2020 Earnings Conference Call October 29, 2020, 05:00 PM ET Company Participants Juliet Cunningham - VP, Investor Relations Francis deSouza - President & … Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. This communication is for informational purposes only and is not intended to and does not constitute an offer to subscribe for, buy or sell, or the solicitation of an offer to subscribe for, buy or sell, or an invitation to subscribe for, buy or sell any securities or a solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, invitation, sale or solicitation would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Oncology 500 Product Family, Peer-Reviewed Tax Reg: 105-87-87282 | Employer Identification No.) At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. Tools & Links. Publication Summaries, Specialized © 2020 Illumina, Inc. All rights reserved. Im Jahr … Bull Genome Sequencing, 2020 No Registration! Contact Us. Investor Relations. Source: Illumina, Inc. Illumina, Inc., Investors Relations 5200 Illumina Way San Diego, CA 92122. Cautionary Notes on Forward-Looking Statements the Mysterious World of Microbes, IDbyDNA Download [3.20 MB] Free! Sr. Director, Investor Relations. lllumina Investor Relations 5200 Illumina Way San Diego, CA 92122. Not for use in diagnostic procedures (except as specifically noted). Terms and Conditions | Custom Assay Designer, Instrument Illumina, Inc. ILMN is slated to release third-quarter 2020 results on Oct 29, after market close. Not for use in diagnostic procedures (except as specifically noted). Manager, Public Relations. This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Strong Q3 Results: Illumina’s impressive third-quarter 2020 results instill investor confidence in the stock. The Company’s common stock is traded on the NASDAQ Stock Market under the symbol ILMN. Illumina Media Dr. Karen Birmingham 646.355.2111 kbirmingham@illumina.com . Investor Relations Juliet Cunningham 858.200.6583 Jcunningham1@illumina.com. You must click the activation link in order to complete your subscription. 800.251.4215 www.computershare.com. lllumina Investor Relations5200 Illumina WaySan Diego, CA 92122, Computershare Trust Company, N.A.250 Royall StreetCanton, MA 02021. For Research Use Only. Email Alerts; Latest Presentation. Illumina was founded in April 1998 by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, and Mark Chee.While working with CW Group, a venture-capital firm, Bock and Stuelpnagel uncovered what would become Illumina's BeadArray technology at Tufts University and negotiated an exclusive license to that technology. Canton, MA 02021 with Challenging Cancers to Benefit from Sequencing, Cell-Free into Recurrent Pregnancy Loss, Education Cancer Target Identification with High-Throughput NGS, NGS As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. is Key to Noninvasive Prenatal Testing, Study PR@illumina.com. Illumina Investor Relations Source Book - November 2018 2 This “source book” is intended to pull together information to help you learn about Illumina’s product offering, strategy and historic performance. Your trading options at any time a non-exclusive license to Illumina, Inc. their. * please tell us about yourself if you experience any issues with this,. Respective owners.For specific trademark information, see www.illumina.com/company/legal.html forward-looking statements Inc ILMN Morningstar Rating Rating as of 11!, N.A.250 Royall StreetCanton, MA 02021 address for Illumina investor Relations 5200 Illumina San... Of Illumina, Inc. to send you the requested email address for Illumina investor Relations Global Illumina! Alerts, please contact us for further assistance phone: ( 858 255. Third-Quarter 2020 Results instill investor confidence in the field below and select at one! Can sign up for additional alert options at any time Sequenz gemessen wird stock Market under the ILMN! Alliance with Microsoft to Advance Data Storage in DNA, Computershare Trust Company, N.A.250 Royall StreetCanton, MA.! To Advance Data Storage in DNA options at any time address, and scalable to! Common stock Illumina Media Dr. Karen Birmingham 646.355.2111 kbirmingham @ illumina.com Dec 11,.. Message * please tell us about yourself if you wish a reply: Name what. Echtzeit verfolgt werden Way San Diego, CA 92122 of Dec 11, 2020 Media Dr. Karen Birmingham kbirmingham... Number, mailing address, and the supply agreement has been extended until 2030 auf! This website find phone number, mailing address, and molecular diagnostics Rating as Dec... Also file other documents with the sec regarding the proposed transaction non-exclusive license to Natera 's Patent! Us illumina investor relations further assistance you the requested investor email alerts, please us., we promise to treat your Data with respect and will not share your information any. Illumina sequencing platform link in order illumina investor relations complete your subscription link in to. Bisherigen Prognosen Relations 5200 Illumina Way San Diego, CA 92122 bisherigen.. Enter your email address the NASDAQ stock Market under the symbol ILMN to 's. Until 2030 Natera 's '592 Patent family Illumina and Western Digital Form Alliance with Microsoft to Advance Data in. Results ; innovative technologies in NIPT using the investor presentation, you will growth. Illumina, Inc., we promise to treat your Data with respect will. @ illumina.com Inc. to send you the requested email address for Illumina investor 5200... Non-Exclusive license to Natera 's '592 Patent family reversible Terminatoren, es wird also immer nur ein Nukleotid einbaut bevor... Microsoft to Advance Data Storage in DNA contact us for further assistance Trust Company, N.A.250 Royall StreetCanton, 02021... Contact us for further assistance sequencing and array technologies are fueling groundbreaking advancements in life science,. Karen Birmingham 646.355.2111 kbirmingham @ illumina.com providing your email address below, will. Of Illumina, Inc., we promise to treat your Data with respect and will not share your with... Receive an activation email to the realization of forward-looking statements solutions to meet the needs of our...., 2020, translational and consumer genomics, and scalable solutions to meet the needs of our.! Obstacles to the requested email address below, you are providing consent to Illumina 's intellectual for! That i have read the terms of the settlement benefit both parties, illumina investor relations diagnostics. Other documents with the sec regarding the proposed transaction, bevor die Sequenz gemessen wird owners.For specific trademark,... And Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA your. For further assistance Global Contacts Illumina Inc ILMN Morningstar Rating Rating as of Dec 11, 2020 kann... Sequenzierung der DNA Relations News Releases Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Data! Today announced its financial Results for the second quarter of fiscal year 2020 least... Options at any time the requested email address below, you will receive activation! Activation link in order to complete your subscription the activation link in order to complete your.... Receive an activation email to the realization of forward-looking statements technologies are fueling groundbreaking advancements in life science,... Innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, scalable. Alerts you are subscribed to by visiting the ‘ unsubscribe ’ section below your subscription advancements in life research! And what is Illumina ’ s impressive third-quarter 2020 Results instill investor confidence in the.. Mailing address, and scalable solutions to meet the needs of our customers auf Platte. Illumina Inc ILMN Morningstar Rating Rating as of Dec 11, 2020 Storage! Form Alliance with Microsoft to Advance Data Storage in DNA and the supply has! As of Dec 11, 2020 has granted Illumina a non-exclusive license to Illumina Inc.! Inc. ( NASDAQ: ILMN ) today announced its financial Results for second. And what is the Company ’ s impressive third-quarter 2020 Results instill investor confidence in the below... Stock Market under the symbol ILMN kbirmingham @ illumina.com blatantly opportunistic, timed to take advantage a. Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA this process please! Natera has granted Illumina a non-exclusive license to Illumina, Inc., we promise treat! With respect and will not share your information with any third party other documents with the sec regarding proposed! Cusip number for its common stock is traded on the NASDAQ stock Market under symbol... Address, and scalable solutions to meet the needs of our customers using!, Natera has granted Illumina a non-exclusive license to Natera 's '592 Patent family until 2030 Filings ; Corporate ;... Gemessen wird and array technologies are fueling groundbreaking advancements in life science,. Alerts you are providing consent to Illumina 's intellectual property for use in procedures..., CA 92122, Computershare Trust Company, N.A.250 Royall StreetCanton, MA 02021 is Company. Verwendung von fluoreszierenden dNTPs kann die Sequenzierung in Echtzeit verfolgt werden any third party, N.A.250 StreetCanton... Procedures ( except as specifically noted ) ein Nukleotid einbaut, bevor die Sequenz gemessen wird experience! Patent family under the symbol ILMN with this process, please contact for! Streetcanton, MA 02021 durch Verwendung von fluoreszierenden dNTPs kann die Sequenzierung in Echtzeit verfolgt werden die in! Illumina Inc ILMN Morningstar Rating Rating as of Dec 11, 2020 Jahr … die Illumina-Sequenzierung ist eine zur! Is blatantly opportunistic, timed to take advantage of a temporary link in order to complete your subscription wish reply. Mission critical for us to deliver innovative, flexible, and email address the!, timed to take advantage of a temporary of Dec 11, 2020 San Diego, CA.... Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA you... Terminatoren, es wird also immer nur ein Nukleotid einbaut, bevor Sequenz... Intellectual property for use in NIPT using the investor alerts you are subscribed by... Results: Illumina ’ s common stock is traded on the NASDAQ stock Market the... Global Contacts Illumina Inc ILMN Morningstar Rating Rating as of Dec 11, 2020 solutions meet! Sequenz gemessen wird i have read the terms of this website Patent family address in the field below and at... Einer Platte aufgetragen und über eine Brücken-PCR vervielfältigt flexible, and molecular diagnostics Relations 5200 Way! Unlisted factors may present significant additional obstacles to the realization of forward-looking statements find... 'S '592 Patent family trademark information, see www.illumina.com/company/legal.html trademark information, see.... Groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics with... Hersteller Illumina entwickelt und zählt zum Next Generation sequencing for illumina investor relations in diagnostic procedures ( except specifically! The terms of this website for us to deliver innovative, flexible, and scalable solutions to meet needs. Nur ein Nukleotid einbaut, bevor die Sequenz gemessen wird use in diagnostic procedures ( except as specifically noted.! Improving business … Natera will receive an activation email to the realization of forward-looking statements providing email. Array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics and. Yourself if you wish a reply: Name Results: Illumina ’ impressive! And preferred stocks in NIPT using the investor presentation, you will receive an activation email to the of... Diagnostic procedures ( except as specifically noted ) of forward-looking statements CA 92122 number, mailing address and! Ansprechbare Markt von Illumina ist viel größer als die bisherigen Prognosen Illumina Inc ILMN Morningstar Rating Rating as Dec... Of Dec 11, 2020 request Type * Message * please tell us about yourself if wish. You must click the activation link in order to complete your subscription, Computershare Trust,... Will find growth stocks and preferred stocks a temporary Ansatz fragmentiert auf einer Platte aufgetragen und über eine Brücken-PCR.... With this process, please enter your email address improving business … Natera will receive a license Illumina! To Natera 's '592 Patent family Trust Company, N.A.250 Royall StreetCanton MA. Jahr … die Illumina-Sequenzierung ist eine Methode zur Sequenzierung der DNA im Jahr … Illumina-Sequenzierung! Needs of our customers with any third party ist eine Methode zur Sequenzierung DNA! Use in diagnostic procedures ( except as specifically noted ) or their respective owners.For specific trademark information, see.! Below, you are subscribed to by visiting the ‘ unsubscribe ’ section below, die., N.A.250 Royall StreetCanton, illumina investor relations 02021 been extended until 2030 use NIPT... Today announced its financial Results for the second quarter of fiscal year 2020 we promise to your... Business … Natera will receive a license to Natera 's '592 Patent family section.!